AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dibto-GM Tablet SR

Prescription Icon
Prescription Required

Marketer

Croise Pharma

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Dibto-GM Tablet SR

Glycemia-Duo SR tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Glycemia-Duo SR should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (sugary foods or juice) are essential to manage hypoglycemia. Alcohol should be avoided due to increased hypoglycemia risk. Additional potential side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests for blood cell counts and liver function.

Uses of Dibto-GM Tablet SR

Adult-onset diabetes

Major Benefits of Dibto-GM Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dibto-GM SR tablet whole; avoid chewing, crushing, or breaking it. Consume this medicine with food.

Common Side effects of Dibto-GM Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Dibto-GM Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dibto-GM SR tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Dibto-GM Tablet SR works:

Gliclazide and metformin are combined in the extended-release Dibto-GM tablet to manage blood sugar.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Dibto-GM Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Dibto-GM tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Dibto-GM tablets are likely not suitable for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Dibto-GM SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Dibto-GM SR tablets. Consult your physician for guidance. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Dibto-GM SR tablets to individuals with hepatic impairment. Dosage modification of Dibto-GM SR tablets may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate Dibto-GM SR tablet therapy at a reduced dosage; the medication is contraindicated in those with severe liver disease.

What if you forget to take Dibto-GM Tablet SR :

Should you forget to take a Dibto-GM Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dibto-GM Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dibto-GM Tablet SR

Dibto-GM SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Dibto-GM Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Dibto-GM Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Dibto-GM Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA—Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Dibto-GM Tablet SR and seek immediate medical attention.
Prolonged use of Dibto-GM Tablet SR can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Patients with known allergies to Dibto-GM Tablet SR components or excipients, or those with moderate-to-severe kidney disease or metabolic acidosis (including diabetic ketoacidosis), should not use this medication.
Combining alcohol and Dibto-GM Tablet SR is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Dibto-GM SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Dibto-GM Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Dibto-GM Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Dibto-GM Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Dibto-GM Tablet SR immediately and seek medical attention.
Prolonged Dibto-GM Tablet SR use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance difficulties), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Patients with known allergies to Dibto-GM Tablet SR components or excipients, or those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis), should not use this medication.
Combining Dibto-GM Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Dibto-GM Tablet SR
48
MRP 58
17% off